File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function

TitleAlternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function
Authors
Wu, HLo, YLuk, TWLau, CSLu, LWMok, MY
Issue Date2015
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk
Citation
The 20th Medical Research Conference (MRC 2015), Department of Medicine, The University of Hong Kong, Hong Kong, 17 January 2015. In Hong Kong Medical Journal, 2015, v. 21 n. 1 suppl. 1, p. 55, abstract no. 90 How to Cite?
AbstractBACKGROUND: Tolerogenic dendritic cells (DCs) are potential cell-based therapy in autoimmune diseases. METHODS: In this study, we generated alternatively activated DCs (aaDCs) by treating monocyte-derived DCs from patients with systemic lupus erythematosus (SLE) and healthy subjects with combination of 1,25 dihydroxyvitamin D(3) (vitD3) and dexamethasone followed by lipopolysaccharide-induced maturation. RESULTS: Lupus aaDCs were found to acquire semi-mature phenotype that remained maturation-resistant to immunostimulants. They produced low level of interleukin-12 (IL-12) but high level of IL-10. They had …
Persistent Identifierhttp://hdl.handle.net/10722/208310
ISSN
1024-2708
2023 Impact Factor: 3.1
2023 SCImago Journal Rankings: 0.261

 

DC FieldValueLanguage
dc.contributor.authorWu, H-
dc.contributor.authorLo, Y-
dc.contributor.authorLuk, TW-
dc.contributor.authorLau, CS-
dc.contributor.authorLu, LW-
dc.contributor.authorMok, MY-
dc.date.accessioned2015-02-23T08:22:07Z-
dc.date.available2015-02-23T08:22:07Z-
dc.date.issued2015-
dc.identifier.citationThe 20th Medical Research Conference (MRC 2015), Department of Medicine, The University of Hong Kong, Hong Kong, 17 January 2015. In Hong Kong Medical Journal, 2015, v. 21 n. 1 suppl. 1, p. 55, abstract no. 90-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/208310-
dc.description.abstractBACKGROUND: Tolerogenic dendritic cells (DCs) are potential cell-based therapy in autoimmune diseases. METHODS: In this study, we generated alternatively activated DCs (aaDCs) by treating monocyte-derived DCs from patients with systemic lupus erythematosus (SLE) and healthy subjects with combination of 1,25 dihydroxyvitamin D(3) (vitD3) and dexamethasone followed by lipopolysaccharide-induced maturation. RESULTS: Lupus aaDCs were found to acquire semi-mature phenotype that remained maturation-resistant to immunostimulants. They produced low level of interleukin-12 (IL-12) but high level of IL-10. They had …-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk-
dc.relation.ispartofHong Kong Medical Journal-
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleAlternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function-
dc.typeConference_Paper-
dc.identifier.emailLo, Y: yloa@hkucc.hku.hk-
dc.identifier.emailLau, CS: cslau@hku.hk-
dc.identifier.emailMok, MY: temy@hkucc.hku.hk-
dc.identifier.authorityLau, CS=rp01348-
dc.identifier.authorityMok, MY=rp00490-
dc.description.naturepublished_or_final_version-
dc.identifier.hkuros242360-
dc.identifier.volume21-
dc.identifier.issue1 suppl. 1-
dc.identifier.spage55, abstract no. 90-
dc.identifier.epage55, abstract no. 90-
dc.publisher.placeHong Kong-
dc.identifier.issnl1024-2708-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats